Cerebras stock rises as Craig-Hallum cites OpenAI deal, tech edge

2 min read     Updated on 09 Jun 2026, 09:01 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Cerebras Systems Inc shares rose significantly following bullish coverage initiations from multiple Wall Street firms, including Craig-Hallum, Needham, and Citigroup. Analysts set price targets ranging from $250 to $340, citing the company's unique Wafer-Scale Engine technology and a major $20 billion compute agreement with OpenAI as key growth drivers. The firm's technology offers substantial performance advantages over competitors, positioning it well in the rapidly expanding AI inference market.

powered bylight_fuzz_icon
42479316

*this image is generated using AI for illustrative purposes only.

Cerebras Systems Inc (NASDAQ: CBRS) shares rose significantly on Monday after multiple Wall Street firms initiated coverage with bullish ratings, reflecting confidence in the company's potential within the artificial intelligence inference market. The stock's rally comes as analysts highlight the firm's unique technology and a major partnership with OpenAI as primary drivers for future growth. Craig-Hallum analyst Richard Shannon initiated coverage with a Buy rating and a price target of $325. Needham, Mizuho, Morgan Stanley, Citigroup, UBS, and Wedbush also began coverage, with price targets ranging from $250 to $340, suggesting substantial upside from current levels.

Analyst Ratings and Price Targets

Needham analyst N. Quinn Bolton initiated coverage with a Buy rating and a price target of $300, citing Cerebras' position as the only supplier of Wafer-Scale Engines. Mizuho analyst Vijay Rakesh set an Outperform rating with a $300 price target, while Morgan Stanley analyst Joseph Moore assigned an Overweight rating and a $250 target. The consensus price forecast stands at $295 based on seven inputs, with a high of $340 from Citigroup and a low of $270 from Wedbush. The three most recent ratings from TD Cowen, UBS, and Citigroup carry an average price forecast of $305.

Strategic Partnerships and Market Drivers

A key catalyst is the January 2026 compute agreement with OpenAI, described as the most important deal in the company's history. The take-or-pay deal is worth more than $20 billion, with OpenAI planning to deploy about 750 megawatts of Cerebras compute capacity through 2028, with an option for another 1.25 gigawatts. Bolton noted that if OpenAI expands the deal, the company's revenue outlook could shift sharply higher. Additionally, Cerebras' collaboration with Amazon.com Inc (NASDAQ: AMZN) Amazon Web Services focuses on disaggregated inference, where AWS Trainium3 chips handle prefilling and Cerebras CS-3 systems handle decoding.

Technology and Performance Advantages

Cerebras' Wafer-Scale Engine integrates 44GB of SRAM, compared with about 178 MB on NVIDIA Corp's (NASDAQ: NVDA) B200 GPU. By keeping SRAM on-chip, the platform offers 2,625 times the memory bandwidth of a B200 GPU and enables 15 times faster inference. This technology is designed for low-latency inference workloads, such as real-time coding and instant research agents. Bloomberg estimates cited in the report show the inference market growing from $66 billion in 2025 to about $292 billion by 2029, representing a 45% compound annual growth rate.

Firm Rating Price Target
Citigroup Buy $340
Craig-Hallum Buy $325
Morgan Stanley Overweight $250
Mizuho Outperform $300
Needham Buy $300
Wedbush - $270
Consensus - $295

Technical Outlook

Technically, the stock is in oversold territory with a Relative Strength Index (RSI) of 28.23, signaling it is prone to sharp counter-trend bounces. Despite the surge, Cerebras is still down 21.02% over the last 12 months. Key resistance is identified at $386.34, the 52-week high from May, while key support sits at $196.73, the 52-week low from June. At the time of publication, Cerebras Systems shares were up 20.01% at $241.04.

What are the potential risks if OpenAI fails to meet the minimum purchase commitments outlined in the take-or-pay agreement?

How will NVIDIA respond to Cerebras' significant memory bandwidth advantage in the inference market?

Can Cerebras scale its manufacturing capacity to meet the projected 750 megawatts of compute demand by 2028?

like17
dislike

TD Cowen initiates coverage on Cerebras Systems with Buy rating

0 min read     Updated on 08 Jun 2026, 10:49 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

TD Cowen analyst Joshua Buchalter has initiated coverage on Cerebras Systems with a Buy rating and a price target of $275, signaling strong confidence in the company's future growth.

powered bylight_fuzz_icon
42484779

*this image is generated using AI for illustrative purposes only.

TD Cowen analyst Joshua Buchalter has initiated coverage on Cerebras Systems with a Buy rating and a price target of $275. This rating reflects a positive outlook on the company's performance and market position.

The analyst's endorsement highlights confidence in Cerebras Systems' potential for growth. The price target of $275 suggests significant upside from current levels, indicating strong future performance expectations.

Key Details

Metric Value
Rating Buy
Price Target $275
Coverage Initiated By Joshua Buchalter

Cerebras Systems, listed on NASDAQ under the ticker CBRS, operates in the technology sector. The initiation of coverage by TD Cowen provides investors with a new perspective on the stock's valuation and prospects.

What specific factors or milestones does TD Cowen expect will drive Cerebras Systems to reach the $275 price target?

How might this coverage initiation influence other analysts' ratings on Cerebras Systems in the near term?

What competitive advantages does Cerebras Systems have that could sustain its growth in the technology sector?

like17
dislike

More News on Cerebras Systems